Is the injection better than a pill
Due to genetic and body composition differences, Asian individuals develop higher visceral fat and significant metabolic risk at a lower BMI threshold of just 27.5
For personal use (buying research peptides for yourself) Risk level: Very low Reality: No documented cases of individuals prosecuted for possessing research peptides for personal use FDA focuses on companies selling, not individual users No federal law criminalizing personal possession of most research peptides (exception: HGH) Worst case scenarios: Customs seizure if importing (lose money, no criminal charges typically) Theoretical future regulation change (unlikely to be retroactive) For selling peptides Risk level: High Reality: FDA actively pursues companies making medical claims Selling as "human medicine" without approval is illegal Companies face warning letters, seizures, potential criminal charges Recent enforcement examples: Companies shut down for marketing unapproved peptides Warning letters issued frequently Criminal charges rare but possible for egregious cases For medical practitioners Risk level: Moderate Reality: Prescribing off-label through compounding pharmacies: Generally safe Operating peptide clinic properly: Legal Making false medical claims: Risk of medical board action Practicing medicine without license: Criminal For athletes Risk level: High (career consequences) Reality: Not criminal prosecution Career-ending bans possible Loss of medals, titles, sponsorships WADA testing increasingly sophisticated Learn about testing concerns in our peptides for athletic performance guide
It also works synergistically with vitamin C to further bolster histamine control and inflammation reduction
LONP1 and cardiovascular diseases Myocardial ischemia/reperfusion (I/R) injury Myocardial I/R injury is induced by mitochondrial oxidative stress and the generation of a large amount of ROS, leading to mitochondrial dysfunction and myocardial cell apoptosis
Dermatology clinicians are increasingly caring for patients on GLP-1s or prescribing the therapy in their own practice
